Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Phase I/II Study of Ruxolitinib with Front-Line Neoadjuvant and Post-Surgical Therapy in Patients with Advanced Epithelial Ovarian; Fallopian Tube; or Primary Peritoneal CancerCIRB: Adult CIRB - Late Phase EmphasisLead Group: NRGStatus: ActiveReview Status: Available to Open
